You are here

Donald Trump

Following up on Trump’s orders, the FDA wants to know: which regulations and paperwork requirements need to go?

Following up on Trump’s orders, the FDA wants to know: which regulations and paperwork requirements need to go?

Endpoints

Flag link:

Has Trump's power over pharma come to an end after Charlottesville?

Has Trump's power over pharma come to an end after Charlottesville?

Pharmafile

pharma industry

Flag link:

Trump signs FDA user fee bill, staving off agency layoffs

Trump signs FDA user fee bill, staving off agency layoffs

BioWorld

Flag link:

J&J’s Alex Gorsky reverses course and jumps ship — just as Trump scuttles top CEO groups

J&J’s Alex Gorsky reverses course and jumps ship — just as Trump scuttles top CEO groups

Endpoints

Flag link:

Amid CEO exits, J&J chief to stay on Trump manufacturing council

Amid CEO exits, J&J chief to stay on Trump manufacturing council

BioPharma Dive

Flag link:

Frazier's call earns him praise, rare for a pharma CEO

Frazier's call earns him praise, rare for a pharma CEO

Medical Marketing and Media

Flag link:

Trump’s renewed broadsides on drug pricing didn’t even dent biopharma this time

Trump’s renewed broadsides on drug pricing didn’t even dent biopharma this time

Endpoints

Flag link:

Why Merck's CEO Needn't Worry About Trump's Drug Pricing Tweet

Why Merck's CEO Needn't Worry About Trump's Drug Pricing Tweet

Forbes

Flag link:

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

Opioid Makers Buffeted by Trump's Declaration of Addiction Crisis

TheStreet.com

INSYS Therapeutics

Flag link:

What You Should Know About Ken Frazier, The CEO Who Just Quit A Trump Advisory Council

What You Should Know About Ken Frazier, The CEO Who Just Quit A Trump Advisory Council

Forbes

Flag link:

Merck CEO Ken Frazier resigns from Trump council in protest, and the president swiftly bites back

Merck CEO Ken Frazier resigns from Trump council in protest, and the president swiftly bites back

Endpoints

Flag link:

Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks?

Could a Trump-mandated cash repatriation spur pharma M&A, or just share buybacks?

Fierce Pharma

Flag link:

Trump says he will declare opioid crisis a national emergency

Trump says he will declare opioid crisis a national emergency

BioPharma Dive

Flag link:

Trump to Sign FDA User Fee Reauthorization Bill

Trump to Sign FDA User Fee Reauthorization Bill

RAPS.org

Flag link:

White House panel urges Trump to declare state of emergency over opioid crisis

White House panel urges Trump to declare state of emergency over opioid crisis

Stat

Flag link:

Eli Lilly CEO expects a Trump executive order on drug pricing this year

Eli Lilly CEO expects a Trump executive order on drug pricing this year

CNBC

Flag link:

Pharma's U.S. reputation is bad—and Trump may be to blame: survey

Pharma's U.S. reputation is bad—and Trump may be to blame: survey

Fierce Pharma

pharma industry

Flag link:

White House doubles down on call to fund FDA entirely with industry fees

White House doubles down on call to fund FDA entirely with industry fees

Endpoints

Flag link:

Buried in Trump’s executive order on drug pricing is a windfall clause for pharma

Buried in Trump’s executive order on drug pricing is a windfall clause for pharma

Stat

pharma industry

Flag link:

US Senate’s FDA User Fee Reauthorization Bill Advances, without $1 Billion Increase Proposed by Trump

US Senate’s FDA User Fee Reauthorization Bill Advances, without $1 Billion Increase Proposed by Trump

Emergo

Flag link: